The rodent preparation, paired with the multi-modal neuromodulation and longitudinal readout toolkit, is the lab's mechanistic platform. This page explains why, and how the rodent platform connects to the lab's NHP and human collaborations through the Pitt human BCI program and other clinical partners.
The rodent preparation, paired with the multi-modal toolkit, is the experimental platform for the lab's cellular and vascular mechanism work. The reason is access. Conditional knockouts and transgenic reporter lines provide cell-type-specific perturbation and labeling that no other preparation offers. Two-photon imaging through chronic windows reveals subcellular dynamics across weeks to months. Parametric stimulation can be repeated across animals at sample sizes (n = 8 to 20 per condition) that support proper statistical inference. Terminal histology integrates the longitudinal in vivo data with quantitative cellular validation.
The same questions cannot be addressed in NHP or human preparations at the same depth, because the genetic, pharmacological, imaging, and sample-size tools required for mechanistic claims are constrained or unavailable in those preparations. This is not a deficiency of NHP and human research, it is a property of the trade-off, those preparations purchase clinical proximity at the cost of mechanistic experimental access.
The lab also operates in NHP and human preparations through collaborations, including the Pitt human BCI program (Drs. Jennifer Collinger and Robert Gaunt) and NHP studies for clinical translation. Mechanism discovered in rodent informs hypotheses tested in NHP and human, and observations from NHP and human work generate questions returned to the rodent platform for mechanistic resolution. Trainees who begin in the rodent platform routinely extend their work into NHP and human collaborations as projects mature, which is the bidirectional translation structure operating across preparations as well as between mechanism and device.
For the prospective trainee, the practical implication is that rodent and multi-modal training does not foreclose the human-translational career, it enables it. The mechanistic depth developed in the rodent platform is what makes a scientist competitive for industry research positions at neural interface companies, for academic faculty positions in basic and translational neuroscience, and for hybrid clinical and translational roles. Students who commit early to NHP-only or human-only training pathways often find that the cellular and mechanistic skill set those preparations did not require is the skill set the post-PhD market most rewards.
The University of Pittsburgh is one of very few institutions that combines foundational neuroscience, device engineering, clinical neurosurgery and rehabilitation, and an active human BCI research program under one institutional umbrella, connected through UPMC and the Center for Neuroscience at the University of Pittsburgh (CNUP). Trainees in the B.I.O.N.I.C. Lab benefit directly from this institutional density. Rodent-platform mechanism produced in the lab can be tested in NHP through collaborations, and findings can be returned to clinical collaborators in the human BCI program for psychophysical and clinical validation, all within the same institution. The cross-preparation structure that the lab operates is uniquely supported by the Pitt environment.